P Braitstein

Summary

Affiliation: University of Bern
Country: Switzerland

Publications

  1. ncbi request reprint Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program
    Paula Braitstein
    British Columbia Centre for Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
    J Infect Dis 193:259-68. 2006
  2. ncbi request reprint Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort
    Paula Braitstein
    British Columbia Center for Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
    AIDS 20:323-31. 2006
  3. pmc Effect of serostatus for hepatitis C virus on mortality among antiretrovirally naive HIV-positive patients
    Paula Braitstein
    Institute for Social and Preventive Medicine, University of Berne, Berne, Switzerland
    CMAJ 173:160-4. 2005
  4. ncbi request reprint Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone
    P Braitstein
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
    AIDS Care 18:690-3. 2006
  5. ncbi request reprint Sexual violence among two populations of men at high risk of HIV infection
    Paula Braitstein
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
    AIDS Care 18:681-9. 2006
  6. ncbi request reprint Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort
    P Braitstein
    Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
    AIDS Care 17:505-15. 2005
  7. ncbi request reprint Use of antiretroviral therapy among HIV positive individuals living in British Columbia
    M Rusch
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    AIDS Care 16:914-22. 2004
  8. pmc Tuberculosis in HIV programmes in lower-income countries: practices and risk factors
    L Fenner
    Institute of Social and Preventive Medicine, Berne, Switzerland
    Int J Tuberc Lung Dis 15:620-7. 2011
  9. ncbi request reprint Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration
    Suely H Tuboi
    Infectious Diseases Epidemiology Research Unit, Graduate School of Public Health and School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    J Acquir Immune Defic Syndr 45:52-9. 2007
  10. ncbi request reprint Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
    Paula Braitstein
    Lancet 367:817-24. 2006

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program
    Paula Braitstein
    British Columbia Centre for Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
    J Infect Dis 193:259-68. 2006
    ..We sought to characterize the impact that hepatitis C virus (HCV) infection has on CD4 cells during the first 48 weeks of antiretroviral therapy (ART) in previously ART-naive human immunodeficiency virus (HIV)-infected patients...
  2. ncbi request reprint Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort
    Paula Braitstein
    British Columbia Center for Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
    AIDS 20:323-31. 2006
    ..To characterize the impact of hepatitis C (HCV) serostatus on adherence to antiretroviral treatment (ART) among HIV-infected adults initiating ART...
  3. pmc Effect of serostatus for hepatitis C virus on mortality among antiretrovirally naive HIV-positive patients
    Paula Braitstein
    Institute for Social and Preventive Medicine, University of Berne, Berne, Switzerland
    CMAJ 173:160-4. 2005
    ..We examined the effect of hepatitis C virus (HCV) seropositivity on risk of death among people receiving their first antiretroviral treatment (ART) for HIV infection...
  4. ncbi request reprint Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone
    P Braitstein
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
    AIDS Care 18:690-3. 2006
    ..54; 95% CI: 0.36-0.82) and believing that hepatitis C was affecting one's health (AOR 1.4; 95% CI: 1.0-2.1). In conclusion, our data indicate more HCV healthcare utilization among those HIV/HCV-co-infected...
  5. ncbi request reprint Sexual violence among two populations of men at high risk of HIV infection
    Paula Braitstein
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
    AIDS Care 18:681-9. 2006
    ..Sexual violence is differentially associated with different health risk behaviors, depending on the age at first occurrence and the primary HIV risk factor (i.e. MSM vs. IDU)...
  6. ncbi request reprint Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort
    P Braitstein
    Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
    AIDS Care 17:505-15. 2005
    ..Although these patients experience poorer quality of life, increased depression and fatigue, this experience appears to be primarily related to socio-economic issues rather than HCV infection...
  7. ncbi request reprint Use of antiretroviral therapy among HIV positive individuals living in British Columbia
    M Rusch
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, University of British Columbia, Vancouver, Canada
    AIDS Care 16:914-22. 2004
    ..The differences in current antiretroviral use by sociodemographic characteristics such as IDU suggest that the need remains to target marginalized populations in order to maximize the health benefits from antiretroviral therapy...
  8. pmc Tuberculosis in HIV programmes in lower-income countries: practices and risk factors
    L Fenner
    Institute of Social and Preventive Medicine, Berne, Switzerland
    Int J Tuberc Lung Dis 15:620-7. 2011
    ..Tuberculosis (TB) is a common diagnosis in human immunodeficiency virus (HIV) infected patients on antiretroviral treatment (ART)...
  9. ncbi request reprint Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration
    Suely H Tuboi
    Infectious Diseases Epidemiology Research Unit, Graduate School of Public Health and School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    J Acquir Immune Defic Syndr 45:52-9. 2007
    ..To assess the frequency of and risk factors for discordant responses at 6 months on highly active antiretroviral therapy (HAART) in previously treatment-naive HIV patients from resource-limited countries...
  10. ncbi request reprint Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
    Paula Braitstein
    Lancet 367:817-24. 2006
    ..We compared baseline characteristics and outcomes during the first year of HAART between HIV-1-infected patients in low-income and high-income settings...
  11. ncbi request reprint Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy
    David M Moore
    BC Centre for Excellence in HIV AIDS, Vancouver, British Columbia, Canada
    Antivir Ther 11:125-9. 2006
    ..We designed a study to determine whether risks for later mortality are similar for HCV-positive and HCV-negative individuals when subjects are stratified on the basis of baseline CD4+ T-cell counts...
  12. pmc Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries
    Martin W G Brinkhof
    Institute of Social and Preventive Medicine ISPM, University of Berne, Finkenhubelweg 11, CH 3012 Bern, Switzerland
    Clin Infect Dis 45:1518-21. 2007
    ..48 (95% confidence interval, 0.36-0.64) in low-income countries and 0.36 (95% confidence interval, 0.26-0.50) in high-income countries. A low CD4 cell count at the start of therapy was the most important risk factor in both settings...
  13. doi request reprint Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration
    Paula Braitstein
    Department of Medicine, Indiana University, Indianapolis, Indiana, USA
    J Womens Health (Larchmt) 17:47-55. 2008
    ....
  14. pmc Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America
    Olivia Keiser
    Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland
    Trop Med Int Health 13:870-9. 2008
    ..To describe temporal trends in baseline clinical characteristics, initial treatment regimens and monitoring of patients starting antiretroviral therapy (ART) in resource-limited settings...
  15. ncbi request reprint Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy
    David M Moore
    British Columbia Centre for Excellence in HIV AIDS, 608 1081 Burrard Street, Vancouver, British Columbia, Canada V6Z 1Y6
    J Acquir Immune Defic Syndr 40:288-93. 2005
    ..To examine the independent association of discordant virologic and immunologic responses to highly active antiretroviral therapy (HAART) with mortality...
  16. ncbi request reprint Safety and tolerability of combination antiretroviral post-exposure prophylaxis in a population-based setting
    Paula Braitstein
    J Acquir Immune Defic Syndr 29:547-8. 2002
  17. ncbi request reprint Sexual violence among a cohort of injection drug users
    Paula Braitstein
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, BC, Canada
    Soc Sci Med 57:561-9. 2003
    ..Nevertheless, women and men are affected differently by sexual violence at different ages, and this has significant implications for health promotion programs, and specifically HIV prevention...
  18. ncbi request reprint Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000
    Paula Braitstein
    British Columbia Centre for Excellence in HIV AIDS, University of British Columbia, Vancouver, British Columbia, Canada
    AIDS 17:2071-5. 2003
    ..To calculate the rate of interventional cardiac procedures (ICP) among HIV-infected individuals ever treated with antiretroviral therapy (ART) and to describe clinical and sociodemographic characteristics associated with ICP...
  19. ncbi request reprint Age, adherence and injection drug use predict virological suppression among men and women enrolled in a population-based antiretroviral drug treatment programme
    Jacqueline M O'Connell
    BC Centre for Excellence in HIV AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    Antivir Ther 8:569-76. 2003
    ..To characterize 1-year virological response to antiretroviral therapy and its determinants by sex...
  20. ncbi request reprint The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users
    Cari L Miller
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, and Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada
    J Acquir Immune Defic Syndr 36:743-9. 2004
    ..The median number of years injecting for youth seroconverting to a secondary infection was 3 years, suggesting that appropriate public health interventions should be implemented immediately...
  21. pmc Impairments, activity limitations and participation restrictions: prevalence and associations among persons living with HIV/AIDS in British Columbia
    Melanie Rusch
    Department of Population Health, British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, Vancouver, Canada
    Health Qual Life Outcomes 2:46. 2004
    ..To measure the prevalence of and associations among impairments, activity limitations and participation restrictions in persons living with HIV in British Columbia to inform support and care programs, policy and research...
  22. ncbi request reprint Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C
    Paula Braitstein
    British Columbia Center for Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
    AIDS 18:2221-34. 2004
    ..Evidence is accumulating regarding the impact of HIV/HCV coinfection on the response to, and safety and tolerability of, antiretroviral therapy (ART) in this population...
  23. ncbi request reprint Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts
    Francois Dabis
    INSERM U 593, ISPED, Universite Victor Segalen, Bordeaux Cedex, France
    Int J Epidemiol 34:979-86. 2005
  24. ncbi request reprint Prescribing practices in a population-based HIV postexposure prophylaxis program
    Paula Braitstein
    Division of Epidemiology and Population Health, BC Centre for Excellence in HIV AIDS, 608 1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada
    AIDS 16:1067-70. 2002
    ..To characterize factors associated with being prescribed triple or double postexposure prophylaxis (PEP) against HIV in a population-based program...
  25. ncbi request reprint Prevalence of activity limitation among persons living with HIV/AIDS in British Columbia
    Melanie Rusch
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, and University of British Columbia, Vancouver, BC
    Can J Public Health 95:437-40. 2004
    ..Little research has examined the types and levels of activity limitations among HIV-positive populations. The objective of this report is to compare the levels of limitations among HIV-positive persons to the general population...
  26. doi request reprint Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia
    Naoufel Azizi
    Laboratoire de Virologie Moleculaire, Centre de recherche du Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    J Gen Virol 89:1716-28. 2008
    ..24) or CIN-1 (5 of 14, P=0.50). HPV-16 E2 polymorphism was a significant factor that influenced measures of HPV-16 integrated viral load...